326 related articles for article (PubMed ID: 32312637)
21. Pancreatic cancer acquires resistance to MAPK pathway inhibition by clonal expansion and adaptive DNA hypermethylation.
Godfrey LK; Forster J; Liffers ST; Schröder C; Köster J; Henschel L; Ludwig KU; Lähnemann D; Trajkovic-Arsic M; Behrens D; Scarpa A; Lawlor RT; Witzke KE; Sitek B; Johnsen SA; Rahmann S; Horsthemke B; Zeschnigk M; Siveke JT
Clin Epigenetics; 2024 Jan; 16(1):13. PubMed ID: 38229153
[TBL] [Abstract][Full Text] [Related]
22. SMC3 epigenetic silencing regulates Rab27a expression and drives pancreatic cancer progression.
Bastos N; Castaldo SA; Adem B; Machado JC; Melo CA; Melo SA
J Transl Med; 2023 Aug; 21(1):578. PubMed ID: 37641131
[TBL] [Abstract][Full Text] [Related]
23. Surveillance Outcome and Genetic Findings in Individuals at High Risk of Pancreatic Cancer.
Rosner G; Scapa E; Ziv T; Gluck N; Ben-Yehoyada M
Clin Transl Gastroenterol; 2024 Feb; 15(2):e00668. PubMed ID: 38147532
[TBL] [Abstract][Full Text] [Related]
24. Surgical and molecular pathology of pancreatic neoplasms.
Hackeng WM; Hruban RH; Offerhaus GJ; Brosens LA
Diagn Pathol; 2016 Jun; 11(1):47. PubMed ID: 27267993
[TBL] [Abstract][Full Text] [Related]
25. Molecular pathological approach to cancer epigenomics and its clinical application.
Kanai Y
Pathol Int; 2024 Apr; 74(4):167-186. PubMed ID: 38482965
[TBL] [Abstract][Full Text] [Related]
26. Contributions of the Microbiome-Derived Metabolome for Risk Assessment and Prognostication of Pancreatic Cancer.
León-Letelier RA; Dou R; Vykoukal J; Yip-Schneider MT; Maitra A; Irajizad E; Wu R; Dennison JB; Do KA; Zhang J; Schmidt CM; Hanash S; Fahrmann JF
Clin Chem; 2024 Jan; 70(1):102-115. PubMed ID: 38175578
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic control of pancreatic cancer metastasis.
Krauß L; Schneider C; Hessmann E; Saur D; Schneider G
Cancer Metastasis Rev; 2023 Dec; 42(4):1113-1131. PubMed ID: 37659057
[TBL] [Abstract][Full Text] [Related]
28. DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma.
Selamat SA; Galler JS; Joshi AD; Fyfe MN; Campan M; Siegmund KD; Kerr KM; Laird-Offringa IA
PLoS One; 2011; 6(6):e21443. PubMed ID: 21731750
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of tumor suppressor genes methylation in circulating tumor DNA of patients with pancreatic cancer.
Xin W; Tu S; Yi S; Xiong Y; Fang K; Sun G; Xiao W
Gene; 2024 Mar; 897():148078. PubMed ID: 38097094
[TBL] [Abstract][Full Text] [Related]
30. Protein Arginine Methyltransferases in Pancreatic Ductal Adenocarcinoma: New Molecular Targets for Therapy.
Bhandari K; Ding WQ
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612768
[TBL] [Abstract][Full Text] [Related]
31. Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts.
Bhagat TD; Von Ahrens D; Dawlaty M; Zou Y; Baddour J; Achreja A; Zhao H; Yang L; Patel B; Kwak C; Choudhary GS; Gordon-Mitchell S; Aluri S; Bhattacharyya S; Sahu S; Bhagat P; Yu Y; Bartenstein M; Giricz O; Suzuki M; Sohal D; Gupta S; Guerrero PA; Batra S; Goggins M; Steidl U; Greally J; Agarwal B; Pradhan K; Banerjee D; Nagrath D; Maitra A; Verma A
Elife; 2019 Nov; 8():. PubMed ID: 31663852
[TBL] [Abstract][Full Text] [Related]
32. Genome-wide DNA methylation and transcriptomic patterns of precancerous gastric cardia lesions.
Liao X; Lin R; Zhang Z; Tian D; Liu Z; Chen S; Xu G; Su M
J Natl Cancer Inst; 2024 May; 116(5):681-693. PubMed ID: 38258659
[TBL] [Abstract][Full Text] [Related]
33. Role of the fatty pancreatic infiltration in pancreatic oncogenesis.
Frendi S; Martineau C; Cazier H; Nicolle R; Chassac A; Albuquerque M; Raffenne J; Le Faouder J; Paradis V; Cros J; Couvelard A; Rebours V
Sci Rep; 2024 Mar; 14(1):6582. PubMed ID: 38503902
[TBL] [Abstract][Full Text] [Related]
34. Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer.
Swierczynski J; Hebanowska A; Sledzinski T
World J Gastroenterol; 2014 Mar; 20(9):2279-303. PubMed ID: 24605027
[TBL] [Abstract][Full Text] [Related]
35. The Effect of Intratumor Heterogeneity in Pancreatic Ductal Adenocarcinoma Progression and Treatment.
Saleh O; Shihadeh H; Yousef A; Erekat H; Abdallh F; Al-Leimon A; Elsalhy R; Altiti A; Dajani M; AlBarakat MM
Pancreas; 2024 May; 53(5):e450-e465. PubMed ID: 38728212
[TBL] [Abstract][Full Text] [Related]
36. [Pancreatic cancer-screening or surveillance?].
Sirtl S; Vornhülz M; Hofmann FO; Mayerle J; Beyer G
Radiologie (Heidelb); 2023 Dec; 63(12):908-915. PubMed ID: 37878016
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic Cancer and Its Mimics.
Miller FH; Lopes Vendrami C; Hammond NA; Mittal PK; Nikolaidis P; Jawahar A
Radiographics; 2023 Nov; 43(11):e230054. PubMed ID: 37824413
[TBL] [Abstract][Full Text] [Related]
38. Biological characteristics of pancreatic ductal adenocarcinoma: Initiation to malignancy, intracellular to extracellular.
Li O; Li L; Sheng Y; Ke K; Wu J; Mou Y; Liu M; Jin W
Cancer Lett; 2023 Oct; 574():216391. PubMed ID: 37714257
[TBL] [Abstract][Full Text] [Related]
39. Protein kinase D1 - A targetable mediator of pancreatic cancer development.
Fleming Martinez AK; Storz P
Biochim Biophys Acta Mol Cell Res; 2024 Feb; 1871(2):119646. PubMed ID: 38061566
[TBL] [Abstract][Full Text] [Related]
40. Biomarker-Based Therapy in Pancreatic Ductal Adenocarcinoma: An Emerging Reality?
Krantz BA; O'Reilly EM
Clin Cancer Res; 2018 May; 24(10):2241-2250. PubMed ID: 29269376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
